? RELIGIOUS ORDERS STUDY CORE The overall goal of the Religious Orders Study Core is to continue to facilitate externally funded high quality research on MCI, AD, and related disorders. The Core supports a variety of studies by investigators at Rush and across the county, including studies of the transition from normality to MCI to AD; studies linking post- mortem findings to the spectrum of cognition from normality, to MCI, to AD; and studies that link genetic and environmental risk factors to post-mortem indices and clinical data obtained proximate to death; studies that support drug discovery pipelines with contemporary high throughput biochemical and molecular techniques; and studies of the causes, consequences, and neurobiology of impaired motor function. The Core will continue recruiting and performing annual evaluations on older members of Catholic Religious Communities without dementia. More than 1,300 participants have enrolled. The overall follow-up rate exceeds 95% with up to 22 waves of data, and the autopsy rate exceeds 90% with more than 650 autopsies. More than 350 peer-reviewed manuscripts have been published including 201 in the past project period. The manuscripts have been published by a wide variety of authors from Rush, and many other NIA-funded AD Centers, and other centers in the United States, Canada, and Europe, and have had a strong and sustained impact on the field The continuation of this Core for five more years will result in up to 27 waves of data on more than 1450 persons and brain tissue from about 800 persons. Such a rich and diverse resource will allow the Core to continue to support numerous investigators. It will also offer the AD research community unprecedented opportunities to mine multi-level omics data to find novel therapeutic targets for all common neurodegenerative diseases of aging.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG010161-27
Application #
9320975
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2017-07-15
Budget End
2018-06-30
Support Year
27
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Rush University Medical Center
Department
Type
DUNS #
068610245
City
Chicago
State
IL
Country
United States
Zip Code
60612
Yu, Lei; Petyuk, Vladislav A; Gaiteri, Chris et al. (2018) Targeted brain proteomics uncover multiple pathways to Alzheimer's dementia. Ann Neurol 84:78-88
Jansen, Willemijn J; Wilson, Robert S; Visser, Pieter Jelle et al. (2018) Age and the association of dementia-related pathology with trajectories of cognitive decline. Neurobiol Aging 61:138-145
Benedet, Andréa L; Yu, Lei; Labbe, Aurélie et al. (2018) CYP2C19 variant mitigates Alzheimer disease pathophysiology in vivo and postmortem. Neurol Genet 4:e216
Tan, Chin Hong; Fan, Chun Chieh; Mormino, Elizabeth C et al. (2018) Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition. Acta Neuropathol 135:85-93
Arvanitakis, Zoe; Leurgans, Sue E; Fleischman, Debra A et al. (2018) Memory complaints, dementia, and neuropathology in older blacks and whites. Ann Neurol 83:718-729
Blue, Elizabeth E; Bis, Joshua C; Dorschner, Michael O et al. (2018) Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer's Disease Sequencing Project. Dement Geriatr Cogn Disord 45:1-17
Ganguli, Mary; Albanese, Emiliano; Seshadri, Sudha et al. (2018) Population Neuroscience: Dementia Epidemiology Serving Precision Medicine and Population Health. Alzheimer Dis Assoc Disord 32:1-9
Wilson, Robert S; Capuano, Ana W; Yu, Lei et al. (2018) Neurodegenerative disease and cognitive retest learning. Neurobiol Aging 66:122-130
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021

Showing the most recent 10 out of 786 publications